Transcutaneous tibial nerve stimulation: 2 years follow-up outcomes in the management of anticholinergic refractory overactive bladder
- 14 Downloads
To evaluate long-term use, efficacy and tolerability of transcutaneous tibial nerve stimulation (TTNS) in the treatment of refractory overactive bladder (OAB).
We performed a prospective observational study and included all patients treated in a single center for OAB persisting after first-line anticholinergic treatment, with ≥ 24 months follow-up. The protocol consisted of daily stimulation at home. The primary outcome was treatment persistence. Amelioration was defined as an improvement in urinary symptom profile (USP) score.
We assessed 84 consecutive patients. After a mean follow-up of 39.3 months and a mean treatment use of 8.3 months, almost two-thirds of patients (71.8%) had discontinued TTNS. Treatment continuation was > 12 months for 28 patients (33.3%) and > 18 months for 16 patients (19%). TTNS was successful following 3 months of treatment in 60 (71%) patients. Mean USP score stayed significantly lower than baseline until 12 months of treatment, but was not significant anymore after 18 months. Discontinuation therapy reasons were a lack of sufficient symptom relief for 59 (70%) patients, compliance difficulty for 5 (6%) patients and becoming asymptomatic for 6 (8%) patients. No serious adverse events occurred.
The present study confirms the utility of TTNS as a treatment option for patients with resistant OAB. In the long-term use, few patients continued with therapy, mostly because of a decreased effectiveness with time.
KeywordsTranscutaneous tibial nerve stimulation Overactive bladder Detrusor overactivity USP
P-AL: data collection and analysis, and manuscript writing/editing. EB: project development and data collection. SL: manuscript editing. ARA: project development. PB: project development, manuscript editing and data analysis. JC: data analysis and manuscript writing/editing
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
- 5.Abrams P, Andersson KE, Birder L et al (2010) Fourth international consultation on incontinence recommendations of the international scientific committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn 29:213–240. https://doi.org/10.1002/nau.20870 CrossRefPubMedGoogle Scholar
- 8.Haab F, Richard F, Amarenco G et al (2008) Comprehensive evaluation of bladder and urethral dysfunction symptoms: development and psychometric validation of the urinary symptom profile (USP) questionnaire. Urology 71:646–656. https://doi.org/10.1016/j.urology.2007.11.100 CrossRefPubMedGoogle Scholar
- 9.De Sèze M, Raibaut P, Gallien P et al (2011) Transcutaneous posterior tibial nerve stimulation for treatment of the overactive bladder syndrome in multiple sclerosis: results of a multicenter prospective study. Neurourol Urodyn 30:306–311. https://doi.org/10.1002/nau.20958 CrossRefPubMedGoogle Scholar
- 15.Peters KM, MacDiarmid SA, Wooldridge LS et al (2009) Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial. J Urol 182:1055–1061. https://doi.org/10.1016/j.juro.2009.05.045 CrossRefPubMedGoogle Scholar
- 19.Souto SC, Reis LO, Palma T et al (2014) Prospective and randomized comparison of electrical stimulation of the posterior tibial nerve versus oxybutynin versus their combination for treatment of women with overactive bladder syndrome. World J Urol 32:179–184. https://doi.org/10.1007/s00345-013-1112-5 CrossRefPubMedGoogle Scholar